Bentham Science Logo

Track Your Manuscript:


Current Cancer Drug Targets

Volume 21, 11 Issues, 2021
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access

Contents

Current Cancer Drug Targets, Volume 17 - Number 3



Review Article

New Perspectives in Glioblastoma: Nanoparticles-based Approaches

, 17(3): 203 - 220

Rosa Luciano, Giulia Battafarano, Rossana Saracino, Michela Rossi, Antonio Perrotta, Melania Manco, Maurizio Muraca and Andrea Del Fattore


DOI: 10.2174/1568009616666160813190732



Review Article

Extracellular Vesicles in Glioblastoma: Role in Biological Processes and in Therapeutic Applications

, 17(3): 221 - 235

Ilaria Giusti, Marianna Di Francesco and Vincenza Dolo


DOI: 10.2174/1568009616666160813182959



Review Article

Hitting a Moving Target: Glioma Stem Cells Demand New Approaches in Glioblastoma Therapy

, 17(3): 236 - 254

Drew A. Spencer, Brenda M. Auffinger, Jason P. Murphy, Megan E. Muroski, Jian Qiao, Yureve Gorind and Maciej S. Lesniak


DOI: 10.2174/1568009616666161215161924



Review Article

Malignant Glioma In Vitro Models: On the Utilization of Stem-like Cells

, 17(3): 255 - 266

Rutger K. Balvers, Clemens M.F. Dirven, Sieger Leenstra and Martine L.M. Lamfers


DOI: 10.2174/1568009616666160813191809



Review Article

Exploiting Microglial Functions for the Treatment of Glioblastoma

, 17(3): 267 - 281

Cinzia Dello Russo, Lucia Lisi, Lucio Tentori, Pierluigi Navarra, Grazia Graziani and Colin K. Combs


DOI: 10.2174/1568009616666160813191240



Review Article

New Approaches in Glioblastoma Multiforme: The Potential Role of Immune- check Point Inhibitors

, 17(3): 282 - 289

Francesca De Felice, Daniela Musio, Raffaele Cassese, Giovanni Luca Gravina and Vincenzo Tombolini


DOI: 10.2174/1568009616666160813183738




Review Article

The Role of EGFR-Met Interactions in the Pathogenesis of Glioblastoma and Resistance to Treatment

, 17(3): 297 - 302

Gao Guo, Ram N. Narayan, Lindsay Horton, Toral R. Patel and Amyn A. Habib


DOI: 10.2174/1568009616666161215162515




Editor-in-Chief

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Current Cancer Drug Targets was launched in 2001. Dr. Ruiwen Zhang serves as the Editor-in-Chief of the journal.

Advertisement

Oct-2021-ban

Related Journals

Related eBooks

eBooks Catalog